Risankizumab for psoriasis

Lancet. 2018 Aug 25;392(10148):616-617. doi: 10.1016/S0140-6736(18)31781-1. Epub 2018 Aug 7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal*
  • Humans
  • Psoriasis*

Substances

  • Antibodies, Monoclonal
  • risankizumab